Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Amphastar Pharmaceuticals, Inc. Director's Dealing 2015

Aug 20, 2015

10216_dirs_2015-08-19_87ead062-6204-4bcb-a5d5-b4c246bcb62c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2015-08-17

Reporting Person: Zhang Jack Y. (Director, CEO & Chief Scientific Officer, 10% Owner)
Reporting Person: Luo Mary Z. (Director, COO and Chief Scientist, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-08-17 Common Stock M 8481 $12.97 Acquired 920117 Direct
2015-08-17 Common Stock M 8481 $12.97 Acquired 670147 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-08-17 Employee Stock Option (right to buy) $12.97 M 8481 Disposed 2015-09-28 Common Stock (8481) Direct
2015-08-17 Employee Stock Option (right to buy) $12.97 M 8481 Disposed 2015-09-28 Common Stock (8481) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7631594 Indirect
Common Stock 5000 Indirect
Common Stock 200000 Indirect

Footnotes

F1: The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife.

F2: The shares are held of record by Applied Physics & Chemistry Laboratories, Inc., of which the reporting persons are the sole owners.

F3: The shares are held of record in an account for the benefit of the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.

F4: The shares are held of record by a trust for the benefit of the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.

F5: Shares subject to the option are fully vested and immediately exercisable.